CRANBURY, N.J., April 27, 2011 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare diseases, today announced that management will host a conference call and live audio webcast on Wednesday, May 4, 2011 to discuss financial results for the first quarter ended March 31, 2011.
